Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check4 days agoChange DetectedVersion v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed from the log. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history page now shows Revision: v3.6.5 instead of v3.6.4, indicating a new interface release; this is a system-level update with no changes to the study data.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history now reflects a new site revision, v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed from the current history.SummaryDifference0.1%

- Check69 days agoChange DetectedAn updated revision (v3.6.2) appears in the record history. The previous revision (v3.6.0) is removed from the history, reflecting a new version entry for the page.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision (v3.6.0) was added, including the recruitment status note 'No longer looking for participants', indicating the study is not enrolling. The older revision identifier (v3.5.5) was removed from the history.SummaryDifference0.6%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.